This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Amelio, R
Right arrow Articles by Matricardi, P M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Amelio, R
Right arrow Articles by Matricardi, P M

 Previous Article  |  Next Article 

Infect Immun. 1988 October; 56(10): 2731-2735

Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines.

R D'Amelio, A Tagliabue, L Nencioni, A Di Addario, L Villa, M Manganaro, D Boraschi, S Le Moli, R Nisini and P M Matricardi

Aeronautica Militare, D.A.S.R.S., Rep. Medicina, Pratica di Mare, Italy.

ABSTRACT

The clinical and immunological responses to typhoid vaccination with parenteral (TAB) and oral (Ty21a) vaccines in two groups of 30 adult male subjects were studied. Parameters monitored included specific anti-Salmonella typhi cell-mediated immunity and total and specific antilipopolysaccharide fecal immunoglobulin A (IgA) titers in Ty21a-vaccinated subjects. Peripheral blood lymphocytes antibacterial activity was significantly increased only in Ty21a-vaccinated subjects. Serum arming activity and results of human F(ab')2 anti-IgG and -IgA inhibition tests suggest antibody-dependent cellular cytotoxicity mediated by IgA in those vaccinated with Ty21a. Interestingly enough, the cells of TAB-vaccinated subjects were able to mediate IgG-dependent cellular cytotoxicity, as was observable from the results of blocking experiments. Moreover, total and specific antilipopolysaccharide fecal IgA levels were observed to be significantly increased with Ty21a, up to 8 months post-vaccination schedule. An early-onset, transitory increase in serum IgM rheumatoid factor was also found, exclusively in subjects treated with TAB, and was no longer detectable on day 240. Ty21a was well tolerated and free of side effects, whereas 65% of subjects administered TAB reported fever, headache, malaise, and local tenderness at the injection site. Our data show that the two typhoid vaccines induce different cell-mediated specific immune responses. The role of these responses in protection against Salmonella infection, however, requires further investigation.


Infect Immun. 1988 October; 56(10): 2731-2735




This article has been cited by other articles:

  • Wang, J. Y., Noriega, F. R., Galen, J. E., Barry, E., Levine, M. M. (2000). Constitutive Expression of the Vi Polysaccharide Capsular Antigen in Attenuated Salmonella enterica Serovar Typhi Oral Vaccine Strain CVD 909. Infect. Immun. 68: 4647-4652 [Abstract] [Full Text]  
  • Viret, J.-F., Favre, D., Wegmuller, B., Herzog, C., Que, J. U., Cryz, S. J. Jr., Lang, A. B. (1999). Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria. Infect. Immun. 67: 3680-3685 [Abstract] [Full Text]